Pursuant to section 20 of the Medicines Act 1981, the Minister of Health granted consent to the distribution in New Zealand of the new medicine listed in the Schedule to a notice published in the New Zealand Gazette, 15 August 2019, Notice 2019-go3775.
This corrigendum amends the notice by replacing the entries:
Product: |
Paracetamol + Ibuprofen |
Active Ingredients: |
Paracetamol 500mgIbuprofen 200mg |
Dosage Form: |
Film coated Tablet |
New Zealand Sponsor: |
PSM Healthcare Limited trading as API Consumer Brands |
Manufacturer: |
Medreich Limited, Bangalore, India |
|
|
Product: |
Tobramycin Wockhardt |
Active Ingredient: |
Tobramycin 300mg |
Dosage Form: |
Solution for inhalation |
New Zealand Sponsor: |
InterPharma (NZ) Limited |
Manufacturers: |
Holopack Verpackungstechnik GmbH, Abstgmund-Untergroningen, Germany |
with
Product: |
Paracetamol + Ibuprofen |
Active Ingredients: |
Paracetamol 500mg |
Dosage Form: |
Film coated Tablet |
New Zealand Sponsor: |
PSM Healthcare Limited trading as API Consumer Brands |
Manufacturer: |
Medreich Limited, Bangalore, India |
|
|
Product: |
Tobramycin Wockhardt |
Active Ingredient: |
Tobramycin 300mg |
Dosage Form: |
Solution for inhalation |
New Zealand Sponsor: |
InterPharma Pty Limited, c/- Healthcare Logistics |
Manufacturers: |
Holopack Verpackungstechnik GmbH, Abstgmund-Untergroningen, Germany |
Dated this 21st day of August 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).